<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>modification_summary_a_042.html</title>
</head>
<body>
<p>* A major pending merger with Aviv REIT has been announced.</p>
<p>* New risk factors related to the proposed merger are now disclosed.</p>
<p>* A previously consolidated entity is no longer included in financial statements.</p>
<p>* The company entered into a new, significantly larger unsecured credit facility.</p>
<p>* The company discloses proposed amendments to its new credit facility.</p>
<p>* A recent large common stock offering was completed.</p>
<p>* The company issued two new series of senior notes.</p>
<p>* The company announced its intention to redeem a series of senior notes.</p>
<p>* A term loan facility established in the prior year was repaid.</p>
<p>* Preferred stock held in an operator, Diversicare, was redeemed.</p>
<p>* A significant portfolio of existing mortgage loans was refinanced and consolidated.</p>
<p>* A significant pending merger with Aviv was newly disclosed.</p>
<p>* Acquisition costs increased substantially due to the pending merger.</p>
<p>* Direct financing lease income grew significantly due to a full year&#x27;s impact.</p>
<p>* Mortgage interest income increased materially from new large mortgage loans.</p>
<p>* Depreciation expense decreased because certain assets became fully depreciated.</p>
<p>* General and administrative expenses grew due to new development costs.</p>
<p>* Impairment provisions increased following the closure of two facilities.</p>
<p>* Other expenses rose due to higher interest expense and new refinancing charges.</p>
<p>* The company established a new, larger unsecured credit facility.</p>
<p>* Two new series of Senior Notes were issued.</p>
<p>* A large common stock offering was completed after the fiscal year-end.</p>
<p>* Plans were disclosed to further amend and expand credit facilities.</p>
<p>* The company announced its intent to redeem a series of senior notes.</p>
<p>* The company issued $250 million of new 4.50% Senior Notes due 2025.</p>
<p>* An investment in Diversicare preferred stock was redeemed, resulting in a gain.</p>
<p>* A $200 million term loan was fully drawn, repaid, and terminated.</p>
<p>* The company issued $400 million of new 4.95% Senior Notes due 2024.</p>
<p>* Investment strategy shifted from direct financing leases to mortgage and property acquisitions.</p>
<p>* The company recognized significantly higher asset impairment losses.</p>
<p>* Loan loss reserves were completely eliminated from a prior balance of $2.0 million.</p>
</body>
</html>
